...
首页> 外文期刊>Journal of Medicinal Chemistry >Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes
【24h】

Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes

机译:人类腺苷激酶抑制剂复合物的晶体结构揭示了两种不同的结合模式

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Adenosine kinase ( AK) is an enzyme responsible for converting endogenous adenosine ( ADO) to adenosine monophosphate ( AMP) in an adenosine triphosphate-( ATP-) dependent manner. The structure of AK consists of two domains, the first a large alpha/beta Rossmann-like nucleotide binding domain that forms the ATP binding site, and a smaller mixed alpha/beta domain, which, in combination with the larger domain, forms the ADO binding site and the site of phosphoryl transfer. AK inhibitors have been under investigation as antinociceptive, antiinflammatory, and anticonvulsant as well as antiinfective agents. In this work, we report the structures of AK in complex with two classes of inhibitors: the first, ADO-like, and the second, a novel alkynylpyrimidine series. The two classes of structures, which contain structurally similar substituents, reveal distinct binding modes in which the AK structure accommodates the inhibitor classes by a 30 rotation of the small domain relative to the large domain. This change in binding mode stabilizes an open and a closed intermediate structural state and provide structural insight into the transition required for catalysis. This results in a significant rearrangement of both the protein active site and the orientation of the alkynylpyrimidine ligand when compared to the observed orientation of nucleosidic inhibitors or substrates.
机译:腺苷激酶(AK)是一种酶,负责以依赖于三磷酸腺苷(ATP)的方式将内源性腺苷(ADO)转化为单磷酸腺苷(AMP)。 AK的结构由两个域组成,第一个域是形成ATP结合位点的大的alpha / beta Rossmann样核苷酸结合域,而较小的混合alpha / beta域则与较大的域结合形成ADO结合位点和磷酸基转移位点。 AK抑制剂已作为抗伤害性,抗炎和抗惊厥药以及抗感染药进行了研究。在这项工作中,我们报告了AK与两种抑制剂的复合物的结构:第一类是类似ADO的抑制剂,第二类是新型的炔基嘧啶系列。包含结构相似取代基的两类结构显示出不同的结合模式,其中AK结构通过小结构域相对于大结构域旋转30圈来容纳抑制剂类。结合模式的这种变化稳定了开放和封闭的中间结构状态,并提供了对催化所需过渡的结构见解。当与观察到的核苷抑制剂或底物的取向相比时,这导致蛋白质活性位点和炔基嘧啶配体的取向均发生显着的重排。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号